Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall bextraPatients who are taking Bextra should be aware of the Bextra complications that can develop as a result of this prescription pain reliever. Bextra is a COX-2 selective non-steroidal anti-inflammatory drug (NSAID) developed by Pfizer. Bextra was approved by the FDA in November 2001 to treat the pain associated with osteoarthritis, rheumatoid arthritis, menstrual pain, and other chronic pain conditions.
Reports of Bextra complications began shortly after this drug was approved by the FDA. Skin-related Bextra complications have caused serious injury to a number of patients who have taken this drug. Stevens Johnson Syndrome is a serious skin condition which may be caused by Bextra complications. This skin condition causes a severe inflammatory eruption of the skin and mucous membranes. Toxic epidermal necrolysis is another serious skin condition that can result from Bextra complications. This condition causes a large portion of the skin to become intensely red and peel in much the same manner as a second degree burn would.
Due to these serious Bextra complications, the FDA and Pfizer have begun negotiations over the inclusion of a black box warning on all Bextra patient product information. The black box warning is the strongest warning the FDA can mandate, short of pulling a drug off the market completely. If a black box warning is approved, Pfizer would be required to outline serious skin related Bextra complications on all written Bextra information and read the warning aloud during all audio commercials.
Other serious Bextra complications are related to cardiovascular and stroke risks. These Bextra complications have been discovered in two different clinical trials involving patients recovering from coronary artery bypass surgery. The trial participants who had received Bextra after undergoing heart surgery were twice as likely to experience serious and life threatening Bextra complications. These Bextra complications include: heart attack, stroke, heart failure, deep venous thrombosis (blood clot), pulmonary embolism (blood clot in the lungs), renal dysfunction and failure, and delayed surgical healing.
These Bextra complications are similar to the serious risks associated with other drugs similar to Bextra. Celebrex studies have found that patients taking higher doses of this pain medication are more than twice as likely to suffer heart attack or stroke. Vioxx was pulled off the market in September 2004, after studies indicated that patients taking Vioxx for more than eighteen months doubled their risk of heart attack or stroke. These findings suggest that Bextra complications may actually be common to all COX-2 selective pain medications.
In addition to these serious Bextra complications, Bextra use has also been associated with a number of other side effects. Other Bextra complications include: gastrointestinal problems, unexplained weight gain, swelling, high blood pressure, jaundice, flu like symptoms, and general fatigue.
If you or a loved one has experienced Bextra complications, you may wish to contact a qualified and experienced attorney who can help determine your legal rights and options in a case to seek relief for your injuries.
Bextra , the popular cox-2 inhibitor recalled by Pfizer, is the subject of another lawsuit.
Rita Fohne has filed her lawsuit against Pfizer in Madison County, Illinois, seeking ...
The U.S. Food and Drug Administration has started issuing alerts to patients and doctors on its new site Drug Watch. Including emerging drug-safety concerns, as well as dangers presented by drugs prescribed for unapproved uses, the new site is in resp...
After a controversial year of drug recalls, the FDA was under attack for failing to adequately protect consumers from dangerous drugs. Currently, the FDA has the Adverse Event Reporting System, or AERS, to collect voluntary reports of possible reactio...